Buy SerenQ Tesamorelin 10mg Peptide Pen – The Ped Shop Europe

The pen format

This is where SerenQ does things differently. Instead of a lyophilised powder that has to be reconstituted, Tesamorelin arrives as a solution already loaded into a graduated injection pen with a dial and a dose window.

• 10mg of Tesamorelin per pen, in solution and ready to use
• 1 unit = 33.3mcg. 9 units on the dial gives 300mcg
• 300 units in total , which works out at 33 full 300mcg draws per pen
• Dial and dose window let you set the exact amount and read it back before dispensing
• 4 screw on pen tips supplied, individually sealed, 32G 0.23 x 4mm
• Protective cap, clip and a rigid retail carton for storage and transport
• Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

• Store refrigerated at 2 to 8°C. Do not freeze
• Keep in the outer carton, away from direct light
• Short periods at room temperature during transit are expected and normal
• Use a fresh sealed tip for each dispense and dispose of tips in a sharps container
• Expiry 12/2027 on sealed, correctly stored stock
• Keep out of reach of children and animals

What is in the box

• 1 × SerenQ Tesamorelin 10mg pre-filled injection pen
• 4 × sealed pen tips, 32G 0.23 x 4mm
• Serialised, QR coded retail carton

Tesamorelin against the other GH-pathway options

Tesamorelin is a stabilised GHRH analogue, so mechanically it sits on the same side as CJC-1295, it raises the ceiling of a growth hormone release rather than triggering one.

What separates it is the research attached to it. Tesamorelin is the GH-pathway compound with the most specific body-composition data, and that data centred on visceral adipose tissue, the fat around the organs rather than under the skin. No other compound in this category carries that.

If the interest is general GH pathway support, the Ipamorelin + CJC-1295 pen is the more common starting point and covers both halves of the mechanism. If the interest is specifically the visceral compartment, tesamorelin is the one with the evidence.

Worth being realistic: that research was conducted in a specific clinical population, not in lean trained individuals, and extrapolating between the two is where disappointment usually comes from.

Guides that go deeper:

• Tesamorelin: what it targets
• HGH kits, pens and secretagogues compared
• Ipamorelin and CJC-1295

For research purposes only

This product is sold strictly as a laboratory research chemical. It is not a medicine, not a supplement and not a cosmetic. It is not for human or veterinary consumption , and it is not intended to diagnose, treat, cure or prevent any disease or condition.

Tesamorelin holds no marketing authorisation from the MHRA or the EMA. Its approval in the United States under the brand Egrifta is a US designation only and does not apply here. Nothing on this page should be read as medical advice, a recommendation, or a suggestion of use in humans or animals.

By purchasing you confirm you are 18 or over , that you are acquiring this product for legitimate laboratory research or analytical use only, and that you accept full responsibility for its safe handling, storage and lawful use under the regulations that apply where you are.